Pharmaceuticals, Biotechnology and Life Sciences
WALTHAM, Mass.–(BUSINESS WIRE)–Palleon Pharmaceuticals, a leading biotech company developing drugs that target the Siglec-Sialoglycan axis to treat cancer, today announced…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes…
SALT LAKE CITY–(BUSINESS WIRE)–PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced…
– Patent expected to provide exclusivity through 2038 – CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company…
-Dr. Scott C. Brun joins Axial Board to support the advancement of the Company’s Autism and Parkinson’s Programs- WALTHAM, Mass.–(BUSINESS…
BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of Dr. John Markels, an…
— Oligomerix’s lead compound targets tau self-association, the initial step before aggregate formation — — Drug reduced tau aggregates in…
New independent analysis by economic policy experts finds Teva saved the US healthcare system $41.9 billion in 2018 $5.9 billion…
Revenue of $2,895 million for the fourth quarter and $11,088 million for the full year Adjusted EBITDA of $642 million…
Viralym-M pivotal and proof-of-concept studies to be initiated in 2020 for treatment and prevention of severe and life-threatening viral diseases…